XLV holdings (2026)
All 59 positions in Health Care Select Sector SPDR Fund, ranked by portfolio weight — led by LLY at 15.4%. Weights come from the fund's own SEC N-PORT filing and update daily with prices; positions in stocks ChartRow doesn't track still appear, ranked by weight, without returns. Not investment advice.
Weights are the Jun 30, 2026 SEC filing rolled forward on each holding’s price move (as of market close, Oct 7, 2026) — an estimate of today, not the filed figure. Switch the table below to see them exactly as filed.
Estimated portfolio characteristics#
Estimated by our own bottom-up analysis of the fund’s SEC-filed holdings, covering 100% of portfolio weight (95% carries a valid trailing P/E). Funds publish similar figures on their own sites; ours are recomputed daily from public data.
XLV holdings by weight#
1–59 of 59| # | Company | Weight | Price | 1D | YTD total | 1Y total | Mkt cap |
|---|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | 15.37% | $1,188.72 | +2.70% | +11.15% | +41.79% | $1.06T |
| 2 | JNJJohnson & Johnson | 10.17% | $258.45 | +1.44% | +26.89% | +39.91% | $623B |
| 3 | ABBVAbbVie Inc. | 7.89% | $271.36 | +1.75% | +21.57% | +20.16% | $480B |
| 4 | MRKMerck & Co. Inc. | 5.81% | $142.79 | +0.60% | +38.45% | +67.77% | $352B |
| 5 | UNHUnitedHealth Group Incorporated Common Stock (DE) | 5.61% | $375.98 | -0.09% | +16.15% | +6.14% | $337B |
| 6 | TMOThermo Fisher Scientific Inc. | 4.05% | $662.06 | +0.83% | +14.57% | +23.22% | $245B |
| 7 | AMGNAmgen Inc. | 3.68% | $413.00 | +2.58% | +28.79% | +43.65% | $223B |
| 8 | GILDGilead Sciences Inc. | 3.01% | $146.82 | +1.80% | +21.80% | +28.86% | $182B |
| 9 | ABTAbbott Laboratories | 2.82% | $98.72 | +0.57% | -19.73% | -24.06% | $171B |
| 10 | PFEPfizer Inc. | 2.63% | $28.00 | +1.82% | +18.25% | +14.06% | $160B |
| 11 | ISRGIntuitive Surgical Inc. | 2.40% | $414.52 | +2.41% | -26.81% | -5.99% | $146B |
| 12 | DHRDanaher Corporation | 2.26% | $218.49 | +1.34% | -3.98% | +5.43% | $154B |
| 13 | VRTXVertex Pharmaceuticals Incorporated | 2.11% | $505.56 | +0.65% | +11.53% | +23.24% | $128B |
| 14 | BMYBristol-Myers Squibb Company | 2.00% | $59.70 | +0.18% | +15.60% | +39.62% | $122B |
| 15 | CVSCVS Health Corporation | 1.84% | $87.95 | +1.76% | +13.41% | +17.66% | $112B |
| 16 | MCKMcKesson Corporation | 1.81% | $910.33 | -1.23% | +11.31% | +21.83% | $106B |
| 17 | MDTMedtronic plc. | 1.79% | $85.51 | -1.81% | -8.70% | -10.16% | $109B |
| 18 | SYKStryker Corporation | 1.57% | $275.40 | -1.01% | -20.97% | -24.59% | $106B |
| 19 | ELVElevance Health Inc. | 1.44% | $404.31 | +1.05% | +17.03% | +15.35% | $88B |
| 20 | REGNRegeneron Pharmaceuticals Inc. | 1.21% | $742.12 | +0.46% | -3.48% | +27.89% | $76B |
| 21 | CIThe Cigna Group | 1.20% | $278.51 | +1.51% | +2.91% | -7.27% | $74B |
| 22 | HCAHCA Healthcare Inc. | 1.13% | $439.17 | +1.61% | -5.43% | +1.05% | $95B |
| 23 | MRNAModerna Inc. | 1.13% | $196.46 | +4.80% | +566.26% | +618.65% | $78B |
| 24 | CORCencora Inc. | 1.02% | $317.25 | +0.28% | -5.51% | +3.55% | $61B |
| 25 | BSXBoston Scientific Corporation | 1.01% | $41.58 | -1.45% | -56.39% | -56.64% | $60B |
| 26 | CAHCardinal Health Inc. | 0.89% | $232.16 | -0.55% | +14.04% | +49.60% | $54B |
| 27 | EWEdwards Lifesciences Corporation | 0.82% | $85.78 | -0.81% | +0.62% | +11.81% | $49B |
| 28 | BDXBecton Dickinson and Company | 0.82% | $180.16 | -0.08% | +20.38% | +22.18% | $49B |
| 29 | AAgilent Technologies Inc. | 0.79% | $169.09 | -0.14% | +25.20% | +22.95% | $48B |
| 30 | HUMHumana Inc. | 0.79% | $396.51 | -1.92% | +55.96% | +35.76% | $48B |
| 31 | IQVIQVIA Holdings Inc. | 0.72% | $258.13 | -0.71% | +14.51% | +28.50% | $42B |
| 32 | WATWaters Corporation | 0.71% | $435.99 | -0.10% | +14.79% | +36.95% | $43B |
| 33 | VEEVVeeva Systems Inc. | 0.70% | $282.50 | -0.35% | +26.55% | -7.75% | $46B |
| 34 | IDXXIDEXX Laboratories Inc. | 0.67% | $506.67 | -1.70% | -25.11% | -19.23% | $40B |
| 35 | RMDResMed Inc. | 0.54% | $225.98 | +2.40% | -5.41% | -19.38% | $33B |
| 36 | BIIBBiogen Inc. | 0.54% | $222.15 | -0.33% | +26.23% | +45.95% | $33B |
| 37 | DXCMDexCom Inc. | 0.53% | $84.30 | +1.09% | +27.02% | +27.67% | $32B |
| 38 | MTDMettler-Toledo International Inc. | 0.51% | $1,533.48 | +0.03% | +9.99% | +17.14% | $31B |
| 39 | CNCCentene Corporation | 0.50% | $64.99 | +0.59% | +57.93% | +69.16% | $32B |
| 40 | ZTSZoetis Inc. | 0.50% | $71.55 | +0.31% | -42.24% | -48.92% | $30B |
| 41 | GEHCGE HealthCare Technologies Inc. Common Stock | 0.49% | $64.67 | -0.15% | -21.04% | -13.02% | $29B |
| 42 | WSTWest Pharmaceutical Services Inc. | 0.43% | $366.48 | -1.65% | +33.51% | +38.22% | $26B |
| 43 | LHLabcorp Holdings Inc. | 0.42% | $311.97 | +0.08% | +25.27% | +12.70% | $25B |
| 44 | DGXQuest Diagnostics Incorporated | 0.41% | $227.00 | -0.61% | +33.05% | +26.93% | $25B |
| 45 | STESTERIS plc (Ireland) | 0.34% | $209.68 | +0.49% | -16.58% | -12.45% | $20B |
| 46 | VTRSViatris Inc. | 0.33% | $17.49 | -0.29% | +43.79% | +78.60% | $20B |
| 47 | INCYIncyte Corp. | 0.31% | $113.44 | +0.63% | +14.85% | +30.14% | $23B |
| 48 | ZBHZimmer Biomet Holdings Inc. | 0.29% | $88.49 | -1.33% | -0.80% | -9.71% | $17B |
| 49 | RVTYRevvity Inc. | 0.29% | $153.60 | +0.20% | +59.08% | +68.91% | $17B |
| 50 | CRLCharles River Laboratories | 0.24% | $300.30 | -1.53% | +50.54% | +76.54% | $14B |
| 51 | SOLVSolventum Corporation | 0.21% | $85.88 | -1.33% | +8.38% | +19.01% | $15B |
| 52 | BAXBaxter International | 0.20% | $23.97 | -1.60% | +25.61% | +4.87% | $12B |
| 53 | TECHBio-Techne | 0.19% | $72.53 | +0.14% | +23.86% | +23.23% | $11B |
| 54 | COOThe Cooper Companies Inc. | 0.18% | $54.75 | -2.98% | -33.20% | -20.68% | $10B |
| 55 | ALGNAlign Technology Inc. | 0.15% | $139.87 | -1.12% | -10.43% | +7.20% | $10B |
| 56 | UHSUniversal Health Services | 0.15% | $174.62 | -1.39% | -19.62% | -16.37% | $10B |
| 57 | PODDInsulet Corporation | 0.15% | $134.36 | -0.27% | -52.73% | -57.14% | $9B |
| 58 | HSICHenry Schein | 0.13% | $83.66 | -1.39% | +10.69% | +28.95% | $9B |
| 59 | DVADaVita Inc. | 0.09% | $176.86 | -1.96% | +55.60% | +34.91% | $11B |
Methodology#
Holdings and weights are sourced from the fund’s portfolio as disclosed to the SEC on Form N-PORT — a public filing. Portfolio filings are quarterly (public ~60 days after quarter end), so we anchor on the latest one and roll each weight forward daily by that holding’s price move, keeping the numbers current between filings; positions in stocks ChartRow doesn’t track carry their filed weight unchanged and show “—” where we have no data. Returns are total returns (dividends reinvested). One row per company, not per ticker: when a fund holds more than one share class of the same company (Alphabet’s GOOGL and GOOG, for example), we combine them into a single row whose weight is the sum of its classes. Past performance does not predict future returns; not investment advice.
FAQ#
- What are the top 10 holdings of XLV?
- XLV's top 10 holdings are Eli Lilly and Company (LLY), 15.4%; Johnson & Johnson (JNJ), 10.2%; AbbVie Inc. (ABBV), 7.9%; Merck & Co. Inc. (MRK), 5.8%; UnitedHealth Group Incorporated Common Stock (DE) (UNH), 5.6%; Thermo Fisher Scientific Inc. (TMO), 4.0%; Amgen Inc. (AMGN), 3.7%; Gilead Sciences Inc. (GILD), 3.0%; Abbott Laboratories (ABT), 2.8%; Pfizer Inc. (PFE), 2.6% — together about 61% of the fund, per its Jun 30, 2026 SEC filing with weights rolled forward to today.
- How many holdings does XLV have?
- Health Care Select Sector SPDR Fund (XLV) held 59 positions as of its latest SEC N-PORT filing (Jun 30, 2026).
- How current are XLV's holdings?
- Funds disclose their full portfolio to the SEC on Form N-PORT; the quarter-end report becomes public about 60 days later. ChartRow anchors on the latest public filing (Jun 30, 2026) and rolls each weight forward daily by that holding's price move, so the weights shown estimate today rather than the filing date.
- Is ChartRow affiliated with XLV or State Street?
- No. ChartRow is independent and is not affiliated with, sponsored by, or endorsed by State Street or Health Care Select Sector SPDR Fund. Everything on this page is derived independently from the fund's public SEC filings; fund names and trademarks belong to their owners. For information only — not investment advice.